The cellular uptake of the tricarboxylic acid cycle (TCA) intermediates is very important for cellular metabolism. However, the transport pathways for these intermediates in liver cells are not well characterized. We have examined the transport of succinate and citrate in the human hepatoma cell line Hep G2 and found that it exhibited a higher rate of succinate compared to citrate transport, which was sodium dependent. Comparison of the transport properties of Hep G2 to that of human retinal pigment epithelial (HRPE) cells transfected with human sodium dicarboxylate transporters, hNaDC-1, hNaDC-3, and hNaCT indicated that Hep G2 cells express a combination of hNaDC-3 and hNaCT. Short period activation of protein kinase C (PKC) by phorbol 12-myristate, 13-acetate (PMA) and α-adrenergic receptor agonist, phenylephrine (PE), downregulated sodium-dependent succinate transport presumably via hNaDC-3. The inhibition by PMA was partially prevented by cytochalasin D, suggesting that PKC reduces the hNaDC-3 activity, at least in part, by increased endocytosis. In contrast, activation of PKA by both forskolin and epidermal growth factor (EGF) had no effect on succinate transport. Our results suggest that Hep G2 cells provide a useful model for studies of diand tricarboxylate regulation of human liver.
Introduction
Numerous studies have reported that the cellular uptake of the tricarboxylic acid cycle (TCA) intermediates, di-and tricarboxylates, is very important for cellular metabolism. They are not only intermediates in the TCA cycle for biological energy production, but also are a source of cytosolic acetyl CoA for the synthesis of fatty acids, isoprenoids, cholesterol, and for the elongation of fatty acids [1] [2] [3] . The mammalian liver is of physiologic importance for the synthesis of fatty acids, isoprenoids, and cholesterol as well as glucose homeostasis, biochemical pathways in which TCA cycle intermediates have critical roles. These intermediates are mainly transported into the cells by sodium-dicarboxylate cotransporters (NaDCs) and the transport processes are classified into the low-and high-affinity transporters based on substrate affinity. The low-affinity sodium dicarboxylate transporter-1 (NaDC-1) prefers succinate as a substrate with a Km value of 0.9 mM and is primarily expressed in the brush border membrane of rabbit and human renal proximal tubule and intestine [4] [5] [6] . The high-affinity sodium dicarboxylate transporter-3 (NaDC-3) is found widely expressed in placenta, brain, liver, kidney, and pancreas of human and rat, with a Km value for succinate in the range of 20-102 μM [7] [8] [9] . Recently, a sodium citrate transporter (NaCT) has been cloned from rat brain [1] and was found to accept citrate as the most preferred substrate.
The intermediates of TCA cycle have been reported to be transported in the liver cells by both sodium-dependent and -independent transport systems [10] [11] [12] [13] [14] [15] [16] . Studies using isolated, perfused rat liver have shown that hepatic uptake of dicarboxylates, such as α-ketoglutarate and malate, is localized in perivenous hepatocytes [12] [13] [14] . Purified plasma membrane vesicles from rat liver contain an electrogenic sodium-dependent transport system for succinate and other dicarboxylates that closely resembles the high-affinity NaDC-3 transporter from the renal basolateral membrane [11, 15, 16] . Sodium-independent transport of α-ketoglutarate has also been reported in basolateral membrane from rat liver [10] . At present, citrate transport in liver cells has not been characterized.
The human hepatoma Hep G2 cells are differentiated cells that display morphological and functional features of normal hepatocyte cells, including synthesis of major plasma proteins and expression of organic solute transporters [17] [18] [19] . These cells provide a useful model system with which to study the regulation of transporters for TCA cycle intermediates. The purpose of the present study was to examine the transport pathways for both succinate and citrate in Hep G2 cell line. The characteristics of succinate and citrate transport found in Hep G2 cells were compared with those of human retinal pigment epithelial (HRPE) cells transiently transfected with human sodium dicarboxylate transporters, hNaDC-1, hNaDC-3, and hNaCT. The main finding is that the transport of succinate and citrate in Hep G2 cells is mediated by a combination of two members of the SLC13 gene family, the human high-affinity sodium dicarboxylate cotransporter, hNaDC-3, and the human sodium citrate cotransporter, hNaCT. The characteristics of succinate and citrate transport found in Hep G2 were consistent with those of succinate and citrate transport described for the hNaDC-3, and hNaCT expressed in HRPE cells. RT-PCR analysis verified the presence of hNaDC-3 and hNaCT transcripts in Hep G2 cells. Furthermore, kinetic analysis in Hep G2 cells revealed a high-affinity succinate transport consistent with hNaDC-3. Finally, the regulation of sodium-dependent succinate transport by PKC and PKA were evaluated. Our experimental data clearly indicated that the Hep G2 cells represent an excellent cell model system for further studies on the regulatory mechanisms of endogenous di-and tricarboxylate transporters.
Methods

Culture of Hep G2 cell line
Hep G2 cells, a human hepatoblastoma carcinoma cell line (The American Type Culture Collection, Manassas, VA) were cultured in DMEM (Hyclone) containing 10% heat-inactivated fetal bovine serum (Hyclone) and 1% penicillin/streptomycin (Hyclone). Cell monolayers were maintained in a humidified incubator at 37°C and 5% CO 2 . Hep G2 cells were plated in 24-well cell culture plates (Corning Inc.) at a density of 3.0 × 10 5 cells/well until they reached confluence, approximately within 4 days.
Functional expression in HRPE cells
Human retinal pigment epithelial (HRPE) cells (Coriell Institute) were transiently transfected with plasmids containing cDNA coding for hNaDC-1 [6, 20] , hNaDC-3 [9] , and hNaCT [2] in pcDNA3.1 vector. They all are kindly provided by Professor Ana M. Pajor (University of Texas Medical Branch, Galveston, Texas). HRPE cells were cultured in Modified Eagle's medium (Gibco/ BRL) supplemented with 10% heat-inactivated fetal bovine serum and 1% penicillin/streptomycin. Prior to transfection, cells were plated at 1.2 × 10 5 cells/ well in 24-well plastic plates. When cell monolayers reached 50-80% confluence, approximately 24 h after plating, cells in each well were transfected with 1.8 μg of FuGENE 6 (Roche Diagnostics Corp., Indianapolis, IN) and 0.6 μg of recombinant plasmid DNA. The cells were incubated for 48 h before measurement of transport activity. Background counts in control cells transfected with pcDNA 3.1 vector were subtracted from counts in experimental cDNA-transfected cells. (5) , and HEPES (25) , pH adjusted to 7.4 with 1 M Tris. In sodium-free transport buffer, NaCl was substituted by 120 mM choline chloride. Uptake experiments were performed at 37°C. Cell monolayers were first washed twice with prewarmed sodium-free transport buffer to remove the medium. The transport reaction was started by the addition of 0.20 ml of transport buffer containing [ 14 C]-substrate and the cells were incubated for 10 min. The transport buffer containing [ 14 C]-substrate was then aspirated off to terminate the uptake and the cells were washed four times with 1 ml of transport buffer without the radiolabeled substrate. Cell monolayers were then solubilized with 0.20 ml of 20% sodium dodecyl sulfate (SDS) and 0.20 ml of the supernatant were transferred to scintillation vials for liquid scintillation counting.
Transport assay
The transport of [ 14 C]-succinate and [ 14 C]-citrate in transfected HRPE cells were measured essentially as described for Hep G2 cells. Uptake into HRPE cells transfected with vector alone was subtracted from cDNA-containing plasmid transfected cells. Before adding radioactive uptake solution, HRPE cells were preincubated for 15 min at room temperature with sodium-containing transport buffer, which help to reduce background counts obtained in these transfected cells.
RT-PCR
Hep G2 cells were cultured in T-75 plastic flasks (Corning Incorporated, NY) and resuspended using 0.25% trypsin-EDTA. Total RNA isolation was then performed using RNeasy Mini kit (QIAGEN) according to manufacturer's instructions. Reverse transcription and PCR were carried out using one-step RT-PCR kit (QIAGEN). The specific primers (BSU Bioservice unit, NSTDA, Thailand) for hNaDC-1, hNaDC-3, and hNaCT are shown in Table 1 . The following reaction cycle was used for the RT-PCR : 50°C for 30 min, 95°C for 15 min, 40-45 cycles of 94°C for 30 s, 56°C for 45 s, and 72°C for 60 s, then followed by a 10-min final extension at 72°C. The quality of the cDNA were assessed by amplification of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (BSU Bioservice unit, NSTDA, Thailand), using the primers 5′-TGA AGG TCG GAG TCA ACG GAT TTG GT-3′ and 5′-CAT GTG GGC CAT GAG GTC CAC CAC-3′. PCR products were separated by electrophoresis in 2% agarose gels and visualized by staining with ethidium bromide.
Na/K-ATPase activity assay
The protocol for cell permeabilization by alamethicin and assay of Na/K-ATPase activity followed the methods of Woolcock and Specht, with some modifications [21] . Briefly, Hep G2 cells were grown in 75 cm 2 tissue culture flasks. After they reached confluence, cells were detached by incubating with 0.25% trypsin-EDTA for 3 min. After centrifugation at 250×g for 5 min at 25°C, cells were then resuspended in warm buffer containing (in mM): HEPES (20) pH 7.4, NaCl (132), KCl (5), MgCl 2 (1.5), CaCl 2 (0.55), glucose (24.5), and 0.2 mg/ ml alamethicin [22] and incubated at 37°C for 20 min. For phorbol 12myristate, 13-acetate (PMA) treated group, 100 nM PMA dissolved in DMSO were added to cell suspension and preincubated at 37°C for 20 min prior to incubating with alamethicin for 20 min. Cells were then cooled briefly in ice prior to Na/K-ATPase activity assay. 5′-GGA GCT GCC AGG GAG TCA AGT G-3′ 5′-GGA GGG GGA TAA AAT GGA GTT TTC-3′
Following the above treatments, ice-cold Na/K-ATPase reaction mixture was added, and maintained on ice. The final composition of Na/K-ATPase reaction mixture in mM, was as follows : HEPES (41) pH 7.4, histidine (40) , ATP (5), NaCl (132), KCl (22.5), MgCl 2 (3.5), CaCl 2 (0.55), and alamethicin 200 μg/ml. Another set of the assay sample contained 5 mM ouabain. The assay was initiated by placing the plate at 37°C, with agitation for 30 min, and then placing onto ice. For cells treated with ouabain, the assay was initiated by incubating cells at 37°C, with agitation for 10 min prior to incubating with ATP. Cells were then lysed with 600 μl of ice cold 0.2 M NaOH, and inorganic phosphate liberated was measured by the method of Carter and Karl [23] , using KH 2 PO 4 as standard. Protein concentration was determined by the method of Lowry et al. [24] using bovine serum albumin as standard. Na/K-ATPase activity was calculated as the difference in inorganic phosphate liberated in the presence and absence of 5 mM ouabain, and expressed as μmol Pi/mg protein/h.
Kinetics analysis
The kinetics of succinate transport in Hep G2 cells were determined by measuring the rate of succinate uptake at varying concentrations of succinate in sodium-containing buffer while the concentration of radiolabeled succinate was kept constant at 10 μM. The kinetics of uptake were examined in the form of the Michaelis-Menten equation using Sigma Plot program (SYSTAT Software Inc.):
The kinetic constants (Michaelis constant, Km and maximal velocity, Vmax) were calculated by using non-linear as well as linear regression methods. V is the rate of substrate transport at concentration equal to [S]. Eadie-Hofstee transformation (V versus V/S) of the same data was also performed.
Data analysis
All uptake measurements were performed with at least three independent experiments. Data are shown as means ± S.E.M. Significant differences from control values were assessed using Student's t-test or one-way ANOVA for multiple comparisons. Significance was accepted at p < 0.05.
Results
Succinate and citrate transport
First, we examined the time-dependent uptake of [ 14 C]succinate and [ 14 C]-citrate into Hep G2 cells. They were linear for at least 15 min. Therefore, all uptake studies were performed with a 10-min incubation period. The uptake assays were done using 10 μM substrate. Succinate and citrate transport in Hep G2 cells were measured in both sodium and choline buffer to compare the rates of sodiumdependent and-independent transport, respectively. As shown in Fig. 1A , Hep G2 cells predominantly transported succinate in a sodium-dependent manner. The sodium-independent transport of succinate was approximately 9% of the total. Transport of citrate (1.08 ± 0.15 pmol/well-min) in Hep G2 cells was much lower than that of succinate (11.22 ± 1.15 pmol/well-min) with the sodium-independent transport being 14% of the total.
The sodium/dicarboxylate transporters from the SLC13 gene family carry both succinate and citrate, but with different affinities. Therefore, we compared the transport of succinate and citrate for hNaDC-1, hNaDC-3, and hNaCT transiently expressed in HRPE cells. As shown in Fig. 1B , the rate of succinate transport by hNaDC-3 (2.48 ± 0.26 pmol/well-min) was much higher than that of hNaDC-1 (0.48 ± 0.06 pmol/well-min), and both hNaDC-1 and hNaDC-3 had very low rates of citrate transport compare to that of succinate. Human NaCT is predominantly a citrate transporter, although it also transports succinate approximately 50% that of citrate. The differences in transport rates could reflect the differences in Km for substrates. The hNaDC-3 had a Km for succinate of about 20 μM, compared with 0.9 mM in hNaDC-1 and approximately 2 mM in hNaCT [3, 9, 20] . The Km for citrate in hNaDC-1 was about 7 mM and 0.6 mM in hNaCT [3, 20] . The Km for citrate in hNaDC-3 has not been reported although the rat NaDC-3 had a Km for citrate of 220 μM [8] . ]-citrate was measured in buffer containing either NaCl or choline chloride after an incubation period of 10 min. Sodiumdependent transport was calculated from the difference between uptake in NaCl and choline chloride. Transport in HRPE cells was measured in NaCl buffer. Data shown are mean ± S.E.M., n = 4 for Hep G2 cells, n = 5 for hNaDC-1, n = 3 for hNaDC-3, and n = 4 for hNaCT.
Hep G2 cells predominantly transport succinate. When expressed as a ratio, the transport of succinate relative to citrate in Hep G2 cells was 12:1 (Fig. 2 ). However, ratios of transport of succinate relative to citrate in both hNaDC-1-and hNaDC-3-transfected HRPE cells were approximately 24:1 and 22:1, respectively and that for NaCT was 0.4:1. A higher succinate:citrate transport ratio would be expected in Hep G2 cells if only NaDC-1 and/or NaDC-3 were present. The lower ratio indicates that NaCT also contributes to enhancing transport of citrate in Hep G2 cells.
RT-PCR analysis of NaDCs expression
RT-PCRs were performed to determine the nature of NaDCs expression in Hep G2 cells. Although our PCR analysis was not aimed to be quantitative, we obtained the expression of hNaDC-3 and hNaCT transcripts, which is consistent with the transport activities in Hep G2 cells ( Fig. 3 ). We also found very low level of hNaDC-1 transcript.
Effects of lithium on succinate and citrate transport
Lithium at millimolar concentrations has been shown to inhibit or activate the sodium-dicarboxylate cotransporters from the SLC 13 gene family [2, 7, 9, 20 ]. Therefore, we tested the effect of 2.5, 10, and 30 mM lithium on sodium-dependent succinate and citrate transport in Hep G2 cells and compared the results with that of HRPE cells transfected with hNaDC-3 and hNaCT. As shown in Fig. 4A , lithium (2.5-30 mM) inhibited succinate transport and stimulated citrate transport in Hep G2 cells in a dose-dependent manner. As shown in Fig. 4B , both succinate and citrate transport by hNaDC-3 expressed in HRPE cells were inhibited by lithium, with a stronger effect on citrate transport. In contrast, both succinate and citrate transport by hNaCT expressed in HRPE cells were stimulated by lithium ; approximately 4-fold and 3.3-fold greater than control, respectively.
Effects of adipate on succinate and citrate transport
High-and low-affinity sodium-dicarboxylate transporters differ in their ability to handle dicarboxylates with more than four carbon atoms, such as glutarate (5 carbons) and adipate (6 carbons). The low-affinity transporter, NaDC-1, prefers four carbon dicarboxylates such as succinate but has a very low affinity for glutarate [20] , whereas dicarboxylates of four-and five-carbon chain length are the ideal substrates for NaDC-3 [9] and citrate (5 carbons) is the most preferred substrate for hNaCT [2] . We tested the effect of adipate on sodium-dependent transport of succinate and citrate in Hep G2 cells compared with HRPE cells expressing hNaDC-3 and hNaCT. In Hep G2 cells, adipate inhibited succinate transport by about 60% but had no effect on citrate transport (Fig. 5A ). In HRPE cells expressing hNaDC-3, the transport of both succinate and citrate were greatly inhibited by adipate, whereas transport of HRPE cells expressing hNaCT was insensitive to adipate ( Fig. 5B ).
3.5. Effect of protein kinase C activation by phorbol 12-myristate, 13-acetate (PMA) on succinate uptake It is noted that Hep G2 cells express more robust NaDC-3 activity than NaCT activity. Therefore, we chose to study the regulatory mechanism of NaDC-3 in this cell line. We first examined the regulatory role of protein kinase C (PKC) on NaDC-3-mediated succinate uptake in Hep G2 cells. Sodiumdependent succinate uptake was examined using both a PKC activator, phorbol 12-myristate, 13-acetate (PMA), and an inhibitor, bisindoylmaleimide I (BIM). As shown in Fig. 6A , ]-citrate was measured after an incubation period of 10 min in buffer containing either NaCl or choline chloride in the absence and presence of LiCl. Sodium-dependent transport was calculated from the difference between uptake in NaCl and choline chloride. Transport in HRPE cells was measured in NaCl buffer in the absence and presence of LiCl. Uptakes are expressed as percent of control. Mean value for succinate and citrate transport in control Hep G2 cells was 10.39 ± 1.17 pmol/ well-min and 0.93 ± 0.14 pmol/well-min, respectively. Mean value of succinate and citrate transport in control hNaDC-3-transfected HRPE cells was 2.48 ± 0.26 pmol/well-min and 0.11 ± 0.01 pmol/well-min, respectively, and mean value of succinate and citrate transport in control hNaCT-transfected HRPE cells was 0.23 ± 0.02 pmol/well-min and 0.54 ± 0.02 pmol/well-min. respectively. The dotted line indicates the position of 100%. Data shown are mean ± S.E.M, n = 4 for Hep G2 cells, n = 5 for hNaDC-1, n = 3 for hNaDC-3, and n = 4 for hNaCT. * denotes significant difference from control, p < 0.05. preincubation of Hep G2 cells with 100 nM PMA resulted in about 60% inhibition of succinate transport. To determine whether the inhibitory effect produced by PMA on succinate transport of Hep G2 cells reflected activation of PKC, we also examined the effect of preincubating Hep G2 cells with 100 nM BIM, which showed no effect on sodium-dependent succinate uptake (Fig. 6A ). When the cells were first preincubated with BIM alone and then the medium was changed to the one containing PMA plus BIM, the inhibitory effect of PMA in the presence of BIM was significantly less than that of PMA alone.
Effect of PKC activation by phenylephrine (PE) on succinate uptake
To determine whether the regulatory action of PKC on NaDC-3-mediated succinate uptake in Hep G2 cells was indirectly mediated via ligand-coupled physiological receptor, succinate uptake was examined using phenylephrine (PE) which is known to activate PKC via an α-adrenergic receptor [25] . As shown in Fig. 6B , preincubation of Hep G2 cells with PE at 1 μM resulted in approximately 55% inhibition of sodium-dependent succinate transport. Similar to the experiment with PMA, the inhibitory effect of PE on succinate uptake in the presence of BIM was significantly less than that of PE alone.
Effects of colchicine and cytochalasin D on PMA-induced inhibition of succinate uptake
To determine whether the inhibitory effect of PMA on sodium-dependent succinate transport in Hep G2 cells involved protein trafficking related to the insertion or deletion of cell surface transporters, colchicine, which disrupts microtubule polymerization [26, 27] , and cytochalasin D, which disrupts actin microfilaments [27, 28] were tested. Hep G2 cells were preincubated in buffer containing 20 μM colchicine for 1 h or 20 μM cytochalasin D for 20 min [29, 30] at 37°C alone or prior to the treatment with PMA. As shown in Fig. 7 , colchicine could not prevent an inhibition of sodium-dependent succinate transport by PMA. In contrast, cytochalasin D could prevent the inhibitory effect of PMA on sodium-dependent succinate transport. In the absence of PMA, neither colchicine nor cytochalasin D influenced sodium-dependent succinate transport.
Kinetics of succinate transport
Kinetic analysis of succinate transport presumably via hNaDC-3 in Hep G2 cells was performed to verify its affinity. In addition, the effect of PKC on the kinetic parameters of succinate uptake was also examined. The Km and Vmax of succinate transport rate was obtained with Km of 95.43 ± 34.37 μM and Vmax of 77.09 ± 27.11 pmol/well-min ( Fig. 8A) . Upon activation of PKC by 100 nM PMA, both Km and Vmax of succinate transport rate in Hep G2 cells were decreased to 28.17 ± 0.84 μM and 47.58 ± 4.73 pmol/well-min, respectively (Fig. 8B ).
Effect of PMA on Na/K-ATPase activity
It was shown that the activity of Na/K-ATPase in various cell types, such as SH-SY5Y human neuroblastoma cells and green monkey kidney COS cells, could be modulated by protein kinases [21, 31] . Activation of PKC inhibited sodium-dependent succinate uptake via hNaDC-3 in Hep G2 cells (Fig. 6A ). To test this possibility we investigated whether PKC can modulate Na/ K-ATPase in our system. Determination of ouabain-sensitive inorganic phosphate released showed that the activity of Na/K-ATPase in HepG2 cells without PMA treatment was 790 ± 11 nmol/mg protein/h. Following incubation with 100 nM PMA for 25 min, Na/K-ATPase activity was not changed (781 ± 15 nmol/mg protein/h).
Effect of forskolin and epidermal growth factor (EGF) on succinate uptake
In addition to PKC, PKA has been shown to play a role in modulating several membrane transport activities [32, 33] . To further determine this possible regulatory action of PKA on NaDC-3-mediated succinate uptake in Hep G2 cells, a potent activator of adenylate cyclase (AC), forskolin that has been extensively used to increase intracellular cAMP level and to elicit cAMP-dependent PKA activation [34] , was tested. In addition, the effect of EGF that has been shown to activate PKA via mitogen-activated protein kinase (MAPK) pathway was also examined [34] . As shown in Fig. 9 , preincubation of Hep G2 cells with either 10 μM forskolin or 10 ng/ml EGF for 10 min had no effect on sodium-dependent succinate transport.
Discussion
The present study was conducted to examine the transport pathways for succinate and citrate in a human hepatoblastoma carcinoma cell line, Hep G2 that retains many characteristics of normal liver cells [17] [18] [19] . The regulatory mechanisms of the predominate transporter, NaDC-3, in Hep G2 cells were also examined. TCA cycle intermediates are not only important for energy production but also are a source of acetyl CoA that enters cholesterol and lipid biosynthetic pathways [35] . Intracellular levels of citrate also regulate the activities of enzymes involved in fatty acid biosynthesis and degradation [35] . Clearly further study is needed to understand the relationship between Fig. 7 . Effects of colchicine and cytochalasin D on PMA-induced inhibition of sodium-dependent [ 14 C]-succinate uptake in Hep G2 cells. Uptake of 10 μM [ 14 C]-succinate was measured after an incubation period of 10 min in buffer containing either NaCl or choline chloride. Sodium-dependent transport was calculated from the difference between uptake in NaCl and choline chloride. Hep G2 cells were preincubated with buffer containing 20 μM colchicine for 1 h or 20 μM cytochalasin D for 20 min at 37°C. After incubation, the solutions were removed followed by three washes with choline buffer and were then incubated with 100 nM PMA for 25 min. Cells were then incubated for 10 min with buffer containing [ 14 C]-succinate to measure succinate uptake. Data shown are mean ± S.E.M of three samples for colchicine treated group and of six samples for cytochalasin D treated group. * denotes a significant difference (p < 0.05), between PMA treatment in the presence and absence of cytochalasin D. ] succinate transport in Hep G2 cells. Uptake was measured after an incubation period of 10 min in buffer containing either NaCl or choline chloride. Sodium-dependent transport was calculated from the difference between uptake in NaCl and choline chloride. The transport uptake was carried out as described in Methods. Each data point represents the mean ± S.E.M. of 3 samples. (B) Effect of PMA on the kinetics of sodium-dependent [ 14 C] succinate transport in Hep G2 cells. PMA at 100 nM was preincubated for 25 min, followed by a 10-min incubation in PMA freebuffer containing [ 14 C]-succinate. Each data point represents the mean ± S.E.M. of 3 samples. Inset : Eadie-Hofstee transformation of the same data. V, uptake rate in pmol/well-min; S, substrate concentration in mM; and V/S is calculated from substrate concentration in micromolar. transport of TCA cycle intermediates and regulation of cholesterol and lipid metabolism. It is possible that the transporters for TCA cycle intermediates in liver cells may be a potential therapeutic target for controlling cholesterol and lipid metabolism in this organ.
We found that the transport pathways for succinate and citrate in Hep G2 cells were predominantly sodium-dependent and were likely to be mediated by a combination of hNaDC-3 and hNaCT. Accordingly, RT-PCR results showed that hNaDC-3 and hNaCT, but not hNaDC-1 genes were transcribed in Hep G2 cells. Succinate transport was greater than that of citrate in Hep G2 cells, it is likely that NaDC-3 activity predominates in these cells. Succinate transport is probably mediated mostly by NaDC-3, as indicated by the inhibition of succinate transport by NaDC-3 inhibitors, lithium and adipate. Citrate transport in Hep G2 cells is probably mediated primarily by NaCT, consistent with a stimulation of citrate transport by lithium and lack of inhibitory effect by adipate.
In addition, the affinity for sodium-dependent succinate transport in Hep G2 cells from kinetic studies suggests that hNaDC-3 mediates the high-affinity transport. The Km for succinate obtained in the present study was 95.43 ± 34.37 μM (Fig. 8A) , consistent with the previous value of 20 μM for the high-affinity hNaDC-3 transporter expressed in HRPE cells, and about 102 μM in oocyte expressing human placenta NaDC-3 system [9] ; and ∼25 μM in oocytes expressing human kidney NaDC-3 [7] . On the other hand, the Km for succinate was found to be 0.9 mM for hNaDC-1 expressed in oocytes [20] and approximately 2 mM for hNaCT transfected in HRPE cells [2] .
Given the significant functional roles of sodium-dependent dicarboxylate transporters in Hep G2 cells, it is important to understand how they are regulated. Although regulation of sodium-dependent NaDC transporters can be examined with cloned transporters expressed in transfected cell systems, it is essential to study the regulatory responses of these processes expressed in their native, intact cells. Previous studies have shown that rat NaDC-1 exhibits adaptive changes to protein abundance and in response to chronic metabolic acidosis and potassium depletion [36] . Besides these studies on chronic effects on sodium-dependent dicarboxylate transporters, acute regulation of hNaDC-1 and winter flounder NaDC-3 (fNaDC-3) have also been studied [37, 38] . It has been reported that NaDC-1 transport activity is markedly inhibited by activators of PKC due to a combination of microtubule-dependent endocytosis of NaDC-1 from the plasma membrane and a direct inhibition of transport activity [38] . The transport activity of fNaDC-3 is also reduced by the PKC activator, PMA, through endocytosis and downregulation of transporter by PKC [37] . However, the acute regulation of hNaDC-3 has not hitherto been studied.
In the present study, we emphasized the investigation of the effect of PKC on sodium-dependent succinate transport (NaDC-3) due to its high activity in Hep G2 cells. As shown in Fig. 6A , a marked inhibition of succinate transport was seen when Hep G2 cells were exposed to PMA. The inhibitory effect was partially antagonized by BIM, a PKC inhibitor. Exposure to BIM alone, however, had no significant effect on sodium-dependent succinate uptake, implying that under basal physiological conditions, succinate transport activity of hNaDC-3 of Hep G2 cells is not under the tonic influence of PKC. We also investigated the indirect activation of PKC through physiological ligand, α1-adrenergic receptor agonist phenylephrine (PE). As shown in Fig. 6B , PE also inhibited sodium-dependent succinate uptake. This inhibition was also partially antagonized by BIM. Although BIM did not completely abolish the inhibitory effect of PMA or PE on hNaDC-3 activity, the significant reduction of succinate transport following exposure to BIM supports the conclusion that activation of PKC exerts a regulatory influence on succinate transport mediated by hNaDC-3. The inability to completely antagonize the effect of PMA or PE by BIM may have been due to suboptimal concentration of BIM used in this study (100 nM) as 50% inhibition of BIM is 200-250 nM [39] . A BIM concentration greater than 100 nM was not employed due to possible nonspecific effects for PKC at high concentration [39] . PMA activates all isoforms of PKC, whereas BIM is most effective at inhibiting PKC group A [40] .
The inhibitory effect of PMA on sodium-dependent succinate transport was associated with an increase in substrate affinity but a decrease in maximal velocity as shown in Fig. 8B . A decrease in maximal velocity was linked to a decrease in the functional transporters in the plasma membrane, suggesting that PKC affects the number of transporters expressed on the cell membrane. The present study found that the effect of PMA on succinate transport was prevented by cytochalasin D, which acts by disrupting actin microfilaments [27, 28, 30] . However, colchicine, which has been shown to affect microtubule polymerization had no effect on succinate transport by PMA (Fig. 7) . Actin Fig. 9 . Effect of forskolin and EGF on rate of [ 14 C] sodium-dependent succinate uptake in Hep G2 cells. Uptake of 10 μM [ 14 C]-succinate was measured after an incubation period of 10 min in buffer containing either NaCl or choline chloride. Sodium-dependent transport was calculated from the difference between uptake in NaCl and choline chloride. The concentrations of forskolin and EGF cells were 10 μM and cells were preincubated for 10 min, followed by a 10-min incubation in forskolin-or EGF-free buffer containing [ 14 C]-succinate. Data shown are mean ± S.E.M of three experiments. Mean control value for succinate transport was 10.05 ± 0.9 pmol/well-min. microfilaments has been shown to play important role in the endocytosis of transporters from apical membranes of polarized cells, such as in MDCK cells and in C6 glioma cells stably expressing the high-affinity neurotensin receptor NTS1 [28, 30] , while microtubule polymerization has been shown to affect exocytosis of phosphate transporter in rat proximal tubule cells [26] . Taken together, our results suggest that a decrease in succinate transport activity by PMA might be explained, at least in part, by increased endocytosis. However, more direct methods (e.g., immunofluorescence and cell membrane capacitance measurements) are needed to verify this notion.
One would expect an increase in succinate uptake to occur in parallel with an increase in its affinity to the transporter. Surprisingly, an inverse relationship was observed between succinate transport rate and substrate affinity after PKC activation. We do not have an adequate explanation for this observation. This finding is similar to that of Groves' study [41] where substrate with high affinity for peritubular organic cation transporter, tetrapentylammonium (TPeA), decreases the efflux of tetraethylammonium (TEA) in rabbit proximal tubule, suggesting that the turnover of carrier is slow when bound to this compound compared with that of an empty or one bound to TEA. Indeed, carrier turnover includes substrate binding, translocation and dissociation [41] . We speculate that there might be a second site not directly involved in translocation where succinate binding following PKC activation produces inhibition and/or slows down turnover rate of the transporter. Another possible explanation could be that activation of PKC with PMA changes the nature of an interaction of NaDC-3 with an unidentified accessory protein which modulates its turnover rate. In addition, the observed changes of the current study in the kinetic parameters of succinate transport after exposure to PMA might involve the phosphorylation of NaDC-3. Eight consensus sequences for PKC-dependent phosphorylation in hNaDC-3 have been reported [9] . Even though the modulation of transport activity of NaDC-1 and fNaDC-3 transiently transfected in oocytes by PKC seems not to involve the PKC phosphorylation sites [37, 38] , there may be different PKC isoforms expressed in Hep G2 cells that are involved in the inhibitory mechanisms of succinate transport of hNaDC-3 by PKC. Further studies are necessary to identify such changes of the transporter.
As succinate uptake via hNaDC-3 involves the parallel activity of Na/K-ATPase [9] , modulation of Na/K-ATPase activity may result in a change in succinate uptake activity of NaDC-3 transporter as well. In fact, both the inhibition and stimulation of Na/K-ATPase activity have been reported in different cell lines and tissues, and in different assay conditions [31] . There are evidences showing that the activity of Na/K-ATPase can be modulated by signaling pathways that involve the activation of PKA and/or PKC [42] . Direct phosphorylation of Na/K-ATPase by PKC has been demonstrated in intact cells and tissues [43] [44] [45] . It was shown that PKC activation also inhibits activity of rat Na/ K-ATPase isoforms expressed in Sf-9 insect cells, rat choroids plexus, and OK cells [44] [45] [46] . Recent studies in human SH-SY5Y cell line also reported that PKC inhibits Na/K-ATPase activity [21] . In the current study, we found that PKC activator, PMA, at the condition which inhibited sodium-dependent succinate uptake via hNaDC-3 had no effect on Na/K-ATPase activity in intact Hep G2 cells. Thus, it appears that the inhibitory effect of PMA on sodium-dependent succinate transport activity reflects a direct effect on the transporters. This is in part by reduction in the number of transporters expressed on the plasma membrane via endocytosis as discussed above.
It has been reported that hNaDC-3 also contains one site for cAMP-dependent protein kinase phosphorylation in addition to PKC-dependent protein kinase [9] . We investigated the influence of PKA on the activity of hNaDC-3-mediated sodium-dependent succinate transport in Hep G2 cells and found that, unlike the effect of PKC, PKA stimulation by forskolin had no effect on succinate uptake ( Fig. 9 ). Previous studies have shown that EGF stimulates the activities of many transporters via indirect activation of PKA [47] [48] [49] . However, EGF had no effect on succinate uptake in Hep G2 cells.
In summary, we have identified sodium-dependent and sodium-independent transporters that mediate succinate and citrate transport in Hep G2 cells. The predominant sodiumdependent pathway for succinate transport in Hep G2 cells is likely to be hNaDC-3, whereas citrate transport is mediated primarily by hNaCT. Kinetic analysis of succinate uptake in Hep G2 cells confirmed its high-affinity property consistent with that of hNaDC-3. Moreover, the current study demonstrated that the sodium-dependent succinate transport in Hep G2 cells was downregulated by PKC but was not affected by PKA. PKC inhibition of the activity of hNaDC-3 could be at least in part be due to microtubule-dependent endocytosis of hNaDC-3 reducing the number of transporter in the plasma membrane. These studies indicate that Hep G2 cells could provide a physiologically relevant cell model for further studies of regulation of endogenous di-and tricarboxylate transporters.
